Cencora to Release Q2 2026 Earnings Results on May 6
Cencora, Inc. (COR), a major pharmaceutical services and drug distribution company, is set to release its Q2 2026 earnings results on May 6. Analysts expect earnings of $4.81 per share, up 8.8% year-over-year, with the company consistently beating estimates in recent quarters. The stock has risen 13.3% over the past year.
Tickers: $COR
Topics: Earnings Financial Performance Market Expectations Pharmaceutical Industry